Quick Answer
Propanc Biopharma, Inc. reported Shares Outstanding of 11.61 million shares for fiscal year 2025.
Propanc Biopharma, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 11.61M | +145411.1% |
| 2024 | 7,980 | -99.9% |
| 2023 | 6.03M | +2637.1% |
| 2022 | 220,351 | -98.4% |
| 2021 | 14.06M | +5345.3% |
| 2020 | 258,120 | -73.3% |
| 2019 | 967,993 | +943.0% |
| 2018 | 92,810 | -98.0% |
| 2017 | 4.55M | +56.2% |
| 2016 | 2.91M | -99.2% |
| 2015 | 347.44M | +378.0% |
| 2014 | 72.68M | +2.9% |
| 2013 | 70.63M | -2.9% |
| 2012 | 72.71M | +1.1% |
| 2011 | 71.92M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 13.45M | +92605.3% | +5.0% |
| September 30, 2025 | 12.81M | -98.1% | +10.3% |
| June 30, 2025 | 11.61M | +145411.1% | +0.0% |
| March 31, 2025 | 11.61M | -89.4% | +79937.1% |
| December 31, 2024 | 14,508 | -100.0% | -100.0% |
| September 30, 2024 | 688.02M | +4538.4% | +8621729.8% |
| June 30, 2024 | 7,980 | -99.9% | -100.0% |
| March 31, 2024 | 109.71M | -95.8% | +203.3% |
- Propanc Biopharma, Inc. showed an increase of +145411.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, Propanc Biopharma, Inc.’s shares outstanding has declined by 83.9% (from 71.92 million shares to 11.61 million shares).
- The most recent figure is from Propanc Biopharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: